sICH and bleeding events of patients
| Outcome | Aspirin, n (%) | DAPT, n (%) | Intravenous t-PA, n (%) |
| sICH (per ECASS II) | 8 (2.1) | ||
| Bleeding (GUSTO） | |||
| Serious | 1 (0.4) | 0 (0.0) | |
| Moderate | 1 (0.4) | 0 (0.0) | |
| Minor | 0 (0.0) | 2 (0.9) | |
| Any bleeding | 2 (0.9) | 1 (0.5) |
DAPT, dual antiplatelet therapy; ECASS II, European Co-operative Acute Stroke Study-II; GUSTO, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; sICH, symptomatic intracranial haemorrhage; t-PA, recombinant tissue plasminogen activator.